For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Dynavax Technologies Corp (NASDAQ: DVAX) closed at $13.63 down -1.73% from its previous closing price of $13.87. In other words, the price has decreased by -$1.73 from its previous closing price. On the day, 1.55 million shares were traded. DVAX stock price reached its highest trading level at $13.89 during the session, while it also had its lowest trading level at $13.6.
Ratios:
For a deeper understanding of Dynavax Technologies Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.11. For the most recent quarter (mrq), Quick Ratio is recorded 9.91 and its Current Ratio is at 10.80. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Sell and sets its target price to $12 from $15 previously.
On February 01, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.JMP Securities initiated its Mkt Outperform rating on September 27, 2022, with a $22 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Novack David F sold 32,764 shares for $14.39 per share. The transaction valued at 471,474 led to the insider holds 22,098 shares of the business.
DAVID NOVACK bought 32,764 shares of DVAX for $471,376 on Mar 07 ’25. On May 31 ’24, another insider, CANO FRANCIS, who serves as the Director of the company, sold 3,615 shares for $11.93 each. As a result, the insider received 43,127 and left with 36,905 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DVAX now has a Market Capitalization of 1691087744 and an Enterprise Value of 1231668352. As of this moment, Dynavax’s Price-to-Earnings (P/E) ratio for their current fiscal year is 78.02, and their Forward P/E ratio for the next fiscal year is 24.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.10 while its Price-to-Book (P/B) ratio in mrq is 2.87. Its current Enterprise Value per Revenue stands at 4.443 whereas that against EBITDA is 223.169.
Stock Price History:
The Beta on a monthly basis for DVAX is 1.23, which has changed by 0.13394344 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, DVAX has reached a high of $14.63, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is 3.70%, while the 200-Day Moving Average is calculated to be 13.85%.
Shares Statistics:
For the past three months, DVAX has traded an average of 2.14M shares per day and 3876480 over the past ten days. A total of 125.45M shares are outstanding, with a floating share count of 118.28M. Insiders hold about 4.67% of the company’s shares, while institutions hold 101.94% stake in the company. Shares short for DVAX as of 1740700800 were 18935730 with a Short Ratio of 8.86, compared to 1738281600 on 19435929. Therefore, it implies a Short% of Shares Outstanding of 18935730 and a Short% of Float of 18.879999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
